Image

Middle East and Africa Lymphedema Treatment Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Published Report
  • Dec 2021
  • MEA
  • 350 Pages
  • No of Tables: 130
  • No of Figures: 48
  • Healthcare
  • Published Report
  • Dec 2021
  • MEA
  • 350 Pages
  • No of Tables: 130
  • No of Figures: 48

Middle East and Africa Lymphedema Treatment Market, By Treatment Type (Compression Therapy, Surgery, Drug Therapy, Laser Therapy and Others), Type (Primary Lymphedema and Secondary Lymphedema), Affected Area (Genital, Lower Extremity, Upper Extremity and Others), Age Group (Adult and Geriatric), Route of Administration (Oral, Injectable and Others), End User (Hospitals, Ambulatory Surgical Centres, Speciality Clinics and Others), Distribution Channel (Direct Tender, Pharmacy Stores, and Others), Country (South Africa, Saudi Arabia, U.A.E., Kuwait, Israel, and Rest of Middle East and Africa)  Industry Trends and Forecast to 2029

Middle East and Africa Lymphedema Treatment Market Market Analysis and Insights: Middle East and Africa Lymphedema Treatment Market

Middle East and Africa lymphedema treatment market is expected to gain significant growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the Middle East and Africa lymphedema treatment market is growing with a CAGR of 5.3% in the forecast period of 2022 to 2029 and is expected to reach USD 14.35 million by 2029 from 9.67 million in 2022. Rising healthcare expenditure and escalation in innovation and technologies are drivers which are expected to the growth of the market in the forecast period.

Lymphedema refers to swelling that generally occurs in upper and lower extremities. Sometimes both arms and both legs swell. Lymphedema is most commonly caused by the removal of or damage to lymph nodes as a part of cancer treatment. It results from a blockage in lymphatic system, which is part of immune system. Stems from a damaged lymphatic system, can lead to infections, disfigurement, debilitating pain and disability. There is no cure for lymphedema.

Lymphedema treatment involves multiple therapies instead of standard treatment, since the patients are dissatisfied or don’t get cured with the conventional treatment of lymphedema. They approach the alternative treatment which offers more control over health care decisions, and the alternatives are found to be more compatible with the patient’s health system.

Lymphedema can occur after any cancer or its treatment that affects lymph node drainage. It has been reported to occur within days and up to 30 years after treatment for breast cancer. The initial stage lymphedema treatments are therapies, surgeries and lymphovenous transplant among others. But there is no permanent cure for lymphedema.

A growing number of people are affected with lymphedema which demand highly effective and advanced treatment to minimize the risk during the treatment. The healthcare systems need highly advanced therapies for numerous lymphedema disorders during the treatment of patients. Therefore, the major market players are highly focusing on product launches and product approvals. Additionally, the government and regulatory bodies are supporting market players by virtue of product approval.

The demand for lymphedema treatment has rapidly increased all over the world during the past decade due to the increased incidence of lymphedema patients.

High cost of treatment and adverse side-effects associated with treatment are anticipated to hinder market growth in the projected period.

Strategic initiatives by the market players, increasing healthcare expenditure, soaring number of drugs manufacturers act as an opportunity for this market and is expected to impel the market growth.

It is expected that no permanent cure for lymphedema is the major key challenge for the future growth of Middle East and Africa lymphedema treatment market.

Middle East and Africa lymphedema treatment market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.  

Middle East and Africa Lymphedema Treatment Market Middle East and Africa Lymphedema Treatment Market and Market Size

Middle East and Africa lymphedema treatment market is segmented on the basis of treatment type, by type, by affected area, by age group, by route of administration, by end user, by distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of treatment type, Middle East and Africa lymphedema treatment market is segmented in compression therapy, surgery, drug therapy, laser therapy and others.  In 2022, compression therapy segment is expected to dominate the market due to lesser cost of therapies with respect to surgeries.
  • On the basis of type, Middle East and Africa lymphedema treatment market is segmented in primary lymphedema and secondary lymphedema.  In 2022, secondary lymphedema segment is expected to dominate the market due to rising awareness about the disease.
  • On the basis of affected area, Middle East and Africa lymphedema treatment market is segmented genital, lower extremity and upper extremity. In 2022, lower extremity segment is expected to dominate the market increasing prevalence of lymphedema.
  • On the basis of age group, the Middle East and Africa lymphedema treatment market is segmented into adult and geriatric. In 2022, adult segment is expected to dominate the market because of increasing drug approvals.
  • On the basis of route of administration, Middle East and Africa lymphedema treatment market is segmented in oral, injectable and others. In 2022, oral segment is expected to dominate the market owing because it is most effective mode administration.
  • On the basis of end user, Middle East and Africa lymphedema treatment market is segmented in hospitals, ambulatory surgical centres, speciality clinics and others. In 2022, hospitals segment is expected to dominate the market due to increasing patients opting for surgeries.
  • On the basis of distribution channel, Middle East and Africa lymphedema treatment market is segmented in direct tender, pharmacy stores and others. In 2022, pharmacy stores segment is expected to dominate the market owing to the rising product launches by the key market players.

Middle East and Africa lymphedema Treatment Market Country Level Analysis

The Middle East and Africa lymphedema treatment market is analyzed and market size information is provided base, by treatment type, by type, by affected area, by age group, by route of administration, by end user, by distribution channel.

Countries covered in the Middle East and Africa lymphedema treatment market report are South Africa, Saudi Arabia, UAE, Egypt, Kuwait, Israel, and rest of Middle East and Africa.

South Africa is expected to dominate the Middle East and Africa lymphedema treatment market due to increasing rising government funding in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.   

Rising healthcare expenditure and escalation in innovations and technologies in the Middle East and Africa lymphedema treatment market are creating new opportunities for players in the Middle East and Africa lymphedema treatment market

Middle East and Africa lymphedema treatment market region segment in the South Africa is expected to grow with the highest rate and it is dominating the region in the forecast period of 2022 to 2029 because of rising government funding.

Middle East and Africa lymphedema treatment market also provides you with detailed market analysis for every country growth in particular industry with the Middle East and Africa lymphedema treatment market sales, impact of advancement in Middle East and Africa lymphedema treatment market and changes in regulatory scenarios with their support for the Middle East and Africa lymphedema treatment market. 

Competitive Landscape and Middle East and Africa Lymphedema Treatment Market Share Analysis

Middle East and Africa lymphedema treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, and technology lifeline curve. The above data points provided are only related to the companies’ focus related to Middle East and Africa lymphedema treatment market.

Major players covered in the report are Bio Compression Systems, Inc., Lohmann & Rauscher, Mego Afek ltd, SIGVARIS, Tactile Systems Technology Inc., medi GmbH & Co. KG, Paul Hartmann AG, Sanyleg S.r.l., 3M, ConvaTec Inc., Julius Zorn GmbH, Cardinal Health, Inc., Smith & Nephew plc, ThermoTek, Huntleigh Healthcare Limited, Herantis Pharma Plc. are Middle East and Africa lymphedema treatment market players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launches and agreements are also initiated by the companies worldwide, which are further accelerating the Middle East and Africa lymphedema treatment market.

For instance,

  • In August 2021, AIROS Medical, Fist Assist Devices Announced Exclusive U.S. Distribution Deal for Fist Assist FA-1 Compression Device. This partnership will boost the market growth of the company.
  • In September 2018, SIGVARIS announced the introduction of SECURE, an innovated garment featuring graduated compression and containment properties for the management of advanced venous edema, lymphedema, post-surgical edema, and general edema. This app launch boosted the market growth by creating awareness among people.


SKU-
Why Choose Us


Frequently Asked Questions